● Recruiting

Assessing the Prevalence and Epidemiological Characteristics of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Autoimmune Gastritis(AIG) Through Hydrogen and Methane Breath Testing(HMBT).

Condition: Autoimmune Gastritis · Sponsor: RenJi Hospital

PhaseN/A

Planned participants220

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

Evaluate the prevalence of small intestinal bacterial overgrowth in patients with autoimmune gastritis (AIG) through hydrogen and methane breath testing, and determine whether there are differences in the positive rates of hydrogen and methane breath testing among the AIG group, the acid suppression group, and the control group.

This description comes directly from the study's public registry record.

Talk to the study team

Ying-xuan Chen Ying-xuan Chen, MD, Ph.D · +86-02158729363 · Yingxuanchen71@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Institute of Digestive Disease

Shanghai, Shanghai Municipality, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06946706